ABOUT TOPAZ

Investment Partners

In a press release, Topaz Pharmaceuticals President and CEO Mr. Nicholas Spring commented on current investment contributions saying, "this round of funding is a significant milestone in the evolution of Topaz Pharmaceuticals."

Current investors:

Aisling Capital
Fidelity Biosciences